Option Care (OPCH) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earni ...

Financial Performance - For the three months ended March 31, 2024, net revenue increased to $1,146,052, representing a 12.8% growth compared to $1,015,848 in the same period of 2023[87] - Gross profit for the first quarter of 2024 was $238,500, with a gross profit margin of 20.8%, down from 22.5% in the prior year[89] - Operating income for the first quarter of 2024 was $69,030, which is 6.0% of revenue, compared to $66,625 or 6.6% of revenue in the same quarter of 2023[87] - Net income for the three months ended March 31, 2024, was $44.8 million, an increase of 14.2% from $39.2 million in the same period of 2023[93] - Net comprehensive income rose to $46.3 million for the three months ended March 31, 2024, compared to $35.8 million for the same period in 2023, reflecting a 29.6% increase[94] Expenses and Costs - Selling, general and administrative expenses increased to $154,742, but as a percentage of revenue, they decreased to 13.5% from 14.6% year-over-year[90] - Total operating expenses for Q1 2024 were $169,470, compared to $162,380 in Q1 2023, reflecting a 4.4% increase[90] - Interest expense, net decreased to $13,202 in Q1 2024 from $13,834 in Q1 2023, reflecting a 4.6% reduction[91] - Income tax expense for the first quarter of 2024 was $12,164, down 19.0% from $15,021 in the same quarter of 2023, with an effective tax rate of 21.4%[92] Cash Flow and Liquidity - Cash and cash equivalents decreased to $219.5 million as of March 31, 2024, down from $343.8 million at the end of 2023[96] - Cash flows from operating activities showed a net cash outflow of $68.8 million for the three months ended March 31, 2024, compared to an inflow of $89.8 million in the same period of 2023, a variance of $158.5 million[106] - The company utilized $40.0 million for common stock repurchases during the three months ended March 31, 2024, compared to $75.0 million in the same period of 2023[109] - The company had $394.7 million of borrowings available under its credit facilities as of March 31, 2024[101] - The company’s cash flows from operations were impacted by the Change Healthcare Cybersecurity Incident, affecting accounts receivable[107] Strategic Initiatives - The increase in net revenue was primarily driven by organic growth in the company's portfolio of therapies, with chronic revenue growing in the mid-teens[89] - The company maintained strong liquidity and resumed claims submission to payers following the Change Healthcare Cybersecurity Incident, which did not materially impact financial results[74] - The company continues to work through accumulated unprocessed claims and establish full recovery with Change Healthcare's applications[73] - The company plans to continue evaluating acquisition opportunities as a key part of its growth strategy[98] - The company’s capital expenditures increased during the three months ended March 31, 2024, compared to the same period in 2023[108] - Interest payments on long-term debt obligations are estimated to total $341.8 million based on current rates as of March 31, 2024[104]

Option Care (OPCH) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.18%. A quarter ago, it was expected that this infusion and home care services company would post earnings of $0.29 per share when it actually produced earnings of $0.32, delivering a surprise of 10.34%.Over the last ...

Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2024 BANNOCKBURN, IL., April 23, 2024 - Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2024. Conference Call Option Care Health will host a conference call to discuss its first quarter 2024 financial results later today ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Option Care (OPCH) , which belongs to the Zacks Medical - Outpatient and Home Healthcare industry.This infusion and home care services company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 8.62%.For the last reported quarter, Option Care came out wi ...

Option Care (OPCH) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.26 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.34%. A quarter ago, it was expected that this infusion and home care services company would post earnings of $0.29 per share when it actually produced earnings of $0.31, delivering a surprise of 6.90%.Over the last ...

• Net revenue of $1,124.4 million, up 9.5% compared to $1,027.2 million in the fourth quarter of 2022 • Gross profit of $247.1 million, or 22.0% of revenue, up 6.9% compared to $231.1 million, or 22.5% of revenue, in the fourth quarter of 2022 • Net income of $57.2 million, or $0.32 earnings per share, inclusive of the impact from non-operating income, compared to net income of $47.5 million, or $0.26 earnings per share in the fourth quarter of 2022 • Adjusted EBITDA of $111.6 million, up 18.4% compared to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) Commission file number: 001-11993 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 05-0489664 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 3000 Lakeside Dr. Suite 300N, Bannockburn, IL 60015 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 312-940-2443 Securities regis ...

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy.Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, ...

shironosov/iStock via Getty ImagesI’m drawn to Option Care Health (NASDAQ:OPCH) in 2024, the leading home infusion provider in the US. There are two pivotal healthcare mega-trends that OPCH is capitalizing on: i. the cost-effective shift to home-based healthcare delivery and ii. the rapid rise of specialty medicines. With a strong operational footprint across the nation and a conservative market estimate of $15bn, I believe OPCH is in a perfect spot to further expand its market through consolidation of ...